OmniStocks retweeted
NEWS: $NSAV NSAV Announces Registration of NSAVxTheVault.com marketwirenews.com/news-releโฆ
#StockMarket #News @RAJURAY48184 @stockscan01 $NLSP $RELI $FORD @nsav_tech
OmniStocks retweeted
#NSAV the leader in the otc now! $204,000,000 revenues!
OmniStocks retweeted
Replying to @DonHollywood22
We need to do better with shareholder engagement and communicating the value of our scientific milestones and their impact on disease diagnosis, treatment, and potential cure. This will change now. We are grateful for your continued faith and support. Onwards and Upwards
OmniStocks retweeted
Replying to @Bradyshonor
Yes, we continue to advance on the planned milestones. The required steps for SPAC are in process and an update on partnerships and progress shall be provided through an official press release and filings in due course. We appreciate your continued faith and patience. #ENZC
OmniStocks retweeted
Sagaliam Acquisition Corp. Class A Common Stock (SAGA) SEC Filings | Nasdaq $ENZC nasdaq.com/market-activity/sโฆ
OmniStocks retweeted
#BGEN continues to make a significant impact in drug discovery and development by utilizing advanced AI technology. Our focus is on safeguarding our assets while expanding our IP portfolio to include #AI -driven monoclonal antibodies. With these antibodies, we aim to revolutionize the fight against #HIV , #COVID19 mutations, and other viruses. Collaborating with pharmaceutical companies, our focus is to cover all viruses in our repository, providing patients with necessary diagnostics and therapies. Our "AI Platform is constantly evolving with disruptive innovations" in healthcare. We are proud to be at the forefront of this crucial work and look forward to continuing to positively impact the world. #ENZC #NASDAQ nasdaq.com/press-release/enzโฆ
OmniStocks retweeted
Enzolytics, Inc. made a groundbreaking move by finalizing a binding business combination agreement with Sagaliam Acquisition Corp. This agreement involved the sale of two innovative companies, Biogenysis, Inc. and Virogentics Inc., in a remarkable transaction valued at a staggering $450,000,000. The future of this combined company looks promising as it is expected to trade on NASDAQ, showcasing its immense potential to investors and the market.
You can find the full article in the link comments.
OmniStocks retweeted
The Company has executed a binding business combination agreement for the purchase of #BGEN & VIRO, operating subsidiaries of Enzolytics Inc. #ENZC The combined company is expected to trade on NASDAQ. finance.yahoo.com/news/sagalโฆ
OmniStocks retweeted
Replying to @DavidM66626845
Excellent. I am pleased that the disruptive potential of this partnership has been realized. #BGEN
OmniStocks retweeted
$ENZC For those needing constant reassurance on the Business Combination Agreement with $SAGA, the company reaffirms that the $450MM deal will be the basis for achieving these objectives.
The deal should be consummated soon. My guess is this month. We're winning 2023 ๐
$ENZC ๐ Press Release ๐
๐ฝ๐๐ค๐๐๐ฃ๐ฎ๐จ๐๐จ, ๐๐ฃ๐. ๐ผ๐ฃ๐ฃ๐ค๐ช๐ฃ๐๐๐จ ๐๐๐ง๐ฉ๐ฃ๐๐ง๐๐ฃ๐ ๐ฌ๐๐ฉ๐ ๐๐๐๐ก๐ฅ๐๐ฎ ๐ผ๐ ๐๐๐ ๐๐ฃ๐ ๐พ๐ค๐ฃ๐ฉ๐๐ฃ๐ฉ๐, ๐๐ฉ๐. ๐ฉ๐ค ๐๐ฃ๐๐ค๐ง๐ฅ๐ค๐ง๐๐ฉ๐ ๐ผ๐ ๐๐ฃ ๐๐๐๐ง๐ค๐๐๐ค๐ข๐ ๐ผ๐ฃ๐๐ก๐ฎ๐จ๐๐จ ๐ฉ๐ค ๐๐๐๐ฃ๐ฉ๐๐๐ฎ ๐ฝ๐๐ค๐ข๐๐ง๐ ๐๐ง๐จ ๐๐ค๐ง ๐๐จ๐ ๐๐ฃ ๐ผ๐๐๐ช๐ง๐๐ฉ๐๐ก๐ฎ ๐๐ง๐๐๐๐๐ฉ๐๐ฃ๐ ๐ผ๐ก๐ฏ๐๐๐๐ข๐๐ง'๐จ ๐ฟ๐๐จ๐๐๐จ๐ ๐๐ฃ๐จ๐๐ฉ ๐๐ฃ๐ ๐๐ง๐๐ซ๐๐ฃ๐ฉ๐๐ค๐ฃ.
1๏ธโฃ Biogenysis is at the forefront of applying AI to create new and improved health therapies.
2๏ธโฃ The structured partnership will combine the efforts and expertise of Biogenysis with those of Khalpey AI Lab and Contenta, Ltd.
3๏ธโฃ Collaborating with Contenta and Khalpey AI Lab will make possible analysis of the gut microbiota of thousands of patients to identify those at higher risk of developing dementia and permit the design of preventative treatments to avoid cognitive decline.
4๏ธโฃ The Company has 4 pending International Patent Applications claiming significant discoveries derived from application of its AI Platform to produce new and effective therapies. Many more developments are planned including the patenting of each๐ฅ
5๏ธโฃ Our partnering with Khalpey AI Lab and Contenta, Ltd. will accelerate the Company's objective to use AI to develop infectious disease therapeutics for improving health care around the world. This partnership and our planned business combination with Sagaliam Acquisition Corporation will provide the basis for achieving this objective ๐ฅ๐ฅ๐ฅ
otcmarkets.com/stock/ENZC/neโฆ
OmniStocks retweeted
The potential for analyzing gut-brain communication with Artificial Intelligence is truly immense. Working with Contenta(Estonia) and @ZainKhalpey AI Lab, we can identify those at higher risk of developing dementia. This can lead to the development of preventative treatments for #Alzheimer's disease and other neurodegenerative diseases.#AI #BGEN #Patent #portfolio
finance.yahoo.com/news/biogeโฆ @KhalpeyLab
OmniStocks retweeted
Replying to @enzolytics
@enzolytics @Virogentics is in #Africa right now starting their pilot clinical trial for #ITV1 to treat #HIV
#GILD
@GileadSciences itโs time to team up and help the people living with this debilitating disease
accesswire.com/774493/Gileadโฆ
#ENZC $ENZC #ENZO ๐ฆฎ
#SAGA $SAGA #VIRO #BGEN
#SCIENCEWILLWIN
#MilOneLion ๐ฆ
OmniStocks retweeted
๐ $ENZC - Exciting News! ๐
Promising progress in HIV treatment!
Virogentics' ITV-1 immunotherapy is shining in clinical trials.
Stay tuned for life-changing updates! #HIVTreatment #ClinicalTrials #HealthcareInnovation
tradersque.com/enzc-enzolytiโฆ
OmniStocks retweeted
Replying to @kshaughnessy2
Thank you for your continuous support. We remain humble and grounded with the ONLY focus on science and milestones. Onwards and upwards...#BGEN
OmniStocks retweeted
Replying to @NatureMedicine
In light of the growing occurrence of #AntimicrobialResistance & the scarcity of viable remedies, it is absolutely crucial to explore new treatment options. One promising avenue involves focusing on the extensively conserved domains present in two-component systems (TCSs). #BGEN
OmniStocks retweeted
$ENZC ๐ฅPRESS RELEASE๐ฅ
1๏ธโฃ Approval for the final protocol from Congos #HIV deparment, Ministry of Health
2๏ธโฃ Administring #ITV1 in HIV patients in August ๐ฅ
3๏ธโฃ Expecting an EMA update!
4๏ธโฃ African partners are Government Leaders & Healthcare Institutions
accesswire.com/769863/Virogeโฆ

























